BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1895194)

  • 1. Flow cytometric DNA analysis of neuroblastoma: prognostic significance of DNA ploidy in unfavorable group.
    Naito M; Iwafuchi M; Ohsawa Y; Uchiyama M; Hirota M; Matsuda Y; Iinuma Y
    J Pediatr Surg; 1991 Jul; 26(7):834-7. PubMed ID: 1895194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors in neuroblastoma. Usefulness of DNA analysis using flow cytometry on paraffin-embedded material].
    Massara FM; Tonello M; Forni M; Fruttero A; Lantermo R; Pugno F; Cordero di Montezemolo L; Ruà S
    Pediatr Med Chir; 1996; 18(2):141-8. PubMed ID: 8767575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of DNA ploidy for neuroblastoma.
    Nakazawa M
    Surg Today; 1993; 23(3):215-9. PubMed ID: 8467172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometric DNA analysis of neuroblastoma and ganglioneuroma. A 10-year retrospective study.
    Taylor SR; Blatt J; Costantino JP; Roederer M; Murphy RF
    Cancer; 1988 Aug; 62(4):749-54. PubMed ID: 3395958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA flow cytometric analysis of neuroblastoma: distinction of tetraploidy subset.
    Kusafuka T; Fukuzawa M; Oue T; Yoneda A; Okada A; Satani M
    J Pediatr Surg; 1994 Apr; 29(4):543-7. PubMed ID: 8014812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
    Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
    J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric DNA analysis of neuroblastoma: correlation with prognostic variables and survival of patients.
    Suzuki H; Takeuchi K
    Jpn J Surg; 1988 Jan; 18(1):116-8. PubMed ID: 3386067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of N-myc oncogene in stage II and IVS neuroblastomas may be a prognostic indicator.
    Nakagawara A; Ikeda K; Tsuda T; Higashi K; Okabe T
    J Pediatr Surg; 1987 May; 22(5):415-8. PubMed ID: 3585663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined determination of N-myc oncogene amplification and DNA ploidy in neuroblastoma. Complementary prognostic indicators.
    Muraji T; Okamoto E; Fujimoto J; Suita S; Nakagawara A
    Cancer; 1993 Nov; 72(9):2763-8. PubMed ID: 8402501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of DNA content in children with neuroblastoma.
    Brenner DW; Barranco SC; Winslow BH; Shaeffer J
    J Pediatr Surg; 1989 Feb; 24(2):204-7. PubMed ID: 2724014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric nuclear DNA content analysis of renal tumors in children: prognostic significance of nuclear DNA ploidy.
    Li P; Yokomori K; Tsuchida Y; Fujita M; Shimizu K; Tanaka E; Pianovski MA; Takemura T
    Tumour Biol; 1995; 16(6):385-93. PubMed ID: 7569685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary dopamine/noradrenaline and dopamine/vanillylmandelic acid ratios as a reflection of different biology of adrenergic clones in children's neuroblastic tumors.
    Izbicki T; Bozek J; Perek D; Wozniak W
    J Pediatr Surg; 1991 Oct; 26(10):1230-4. PubMed ID: 1779334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective analysis of biological factors in a recurrent IV-S neuroblastoma with intermediate-grade malignancy.
    Ikeda H; Nagashima K; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M; Hirato J
    J Pediatr Surg; 1995 Jun; 30(6):866-9. PubMed ID: 7666325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma.
    Bourhis J; Bénard J; DeVathaire F; Wilson GD; Hartmann O; Terrier-Lacombe MJ; Boccon-Gibod L; Lemerle J; Riou G
    Prog Clin Biol Res; 1991; 366():107-13. PubMed ID: 2068130
    [No Abstract]   [Full Text] [Related]  

  • 15. N-myc amplification in neuroblastomas: histopathological, DNA ploidy, and clinical variables.
    Oppedal BR; Oien O; Jahnsen T; Brandtzaeg P
    J Clin Pathol; 1989 Nov; 42(11):1148-52. PubMed ID: 2584426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective study of prognostic value of DNA ploidy and proliferative activity in neuroblastoma.
    Huddart SN; Muir KR; Parkes SE; Mann JR; Stevens MC; Raafat F; Smith K
    J Clin Pathol; 1993 Dec; 46(12):1101-4. PubMed ID: 8282832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometric analysis of nuclear DNA heterogeneity in gastric cancer.
    Imada T; Yamamoto Y; Fukuzawa K; Rino Y; Suda T; Moriwaki Y; Akiyama H; Doi T; Kito F; Takemura H
    Jpn J Clin Oncol; 1997 Aug; 27(4):221-6. PubMed ID: 9379507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA content and proliferative activity in children with neuroblastoma.
    Yalçin B; Kutluk T; Kansu E; Göğüş S; Canpinar H; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2000; 17(1):45-54. PubMed ID: 10689714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
    Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
    N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: a prospective flow cytometric study.
    Lanza G; Gafà R; Santini A; Maestri I; Dubini A; Gilli G; Cavazzini L
    Cancer; 1998 Jan; 82(1):49-59. PubMed ID: 9428479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.